With only $41 million in cash, Tvardi Therapeutics may need to raise additional funds within a one-year period. Click here to ...
Univariate analysis showed that factors such as grade level, family economic status, reasons for choosing nursing major, exposure to AI related courses/training, and daily AI usage time had ...
Financially, Compass Pathways is well-capitalized with $221.9 million in cash, funding operations into 2027. Click here to ...
DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...
Background Many observational studies highlight clonal haematopoiesis (CH) as a novel determinant of cardiovascular disease ...
Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise after chemotherapy can improve cancer-related cognitive impairment. However, ...
Objective To inform the development of an evidence synthesis taxonomy, we aimed to identify and examine all classification ...
This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...
AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...
Disturbance of Consciousness, Neuromodulation Techniques, Deep Brain Stimulation, Electrical Stimulation of the Vagus Nerve ...
They’re harnessing it to help directors prepare, debate, and decide. by Stanislav Shekshnia and Valery Yakubovich In 2014 Hong Kong–based Deep Knowledge Ventures formally appointed an algorithm to its ...
Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca's IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically ...